An engineering and government services company is sitting 37% below its 52-week high, while its CFO and a director bought shares personally in May, and the Mission Technology Solutions spinoff heading to market in January 2027 just got a named CEO and CFO designate.
Stay with this, and you get the breakdown of whether the insider signal, the two recent defense contract wins, and the January catalyst make this worth owning before the re-rating happens.
Standout Picks Now (Sponsored)
Every market cycle produces a handful of companies that dramatically outperform the rest.
Our latest screening has identified the 5 Stocks Set to Double — companies showing rare early-stage momentum traits.
These picks carry the same indicators that historically precede strong rallies.
Past reports highlighted stocks that surged +175%, +498%, and +673%.
Get the Free 5 Stocks Set to Double Report.
*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.
The CFO and a Director Bought Stock Personally in May and Then Contracts Landed in June
KBR, Inc. (NYSE: KBR) is sitting around $33 per share, down from a 52-week high of $52.23. That is a 37% drawdown on a company that just beat Q1 2026 earnings estimates, expanded margins, and watched two significant defense contracts arrive within weeks of each other.
The gap between the price and the activity inside the business is the setup.
In May 2026, director Von Thaer Lewis purchased 3,000 shares in the open market. CFO Shad Evans also bought. Not restricted stock, not option exercises.
Open-market purchases at depressed prices by a CFO and a sitting director.
Then, in June, MTS won a $95 million Space Force digital engineering contract and an $8 billion ceiling Antarctic Science and Engineering Support Contract from the National Science Foundation.
Director Von Thaer Lewis bought 3,000 shares in May 2026: Open-market purchase at current depressed levels.
CFO Shad Evans also bought shares in May 2026: The person who reads the balance sheet every day voted with his wallet.
$95M Space Force contract won in June 2026: Five-year digital engineering for the Air Force Research Laboratory.
$8B ceiling Antarctic contract won in June 2026: Long-duration work for the National Science Foundation.
The stock barely moved on any of it. That is the disconnect.
Action: Buy KBR at $32-$34. Insider buying plus two contract wins while sitting 37% off the high is the setup. Exit if Q2 EPS comes in below $0.90.
Elite Picks (Sponsored)
This report focuses on a narrow group of stocks identified through a detailed screening process.
Analysts apply a combination of metrics to narrow down potential opportunities.
Past selections have shown strong momentum, but no outcomes are guaranteed.
The newest edition is now open for access.
Get the report now
*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.
The Spinoff Has Named Leadership, and January 2027 Is a Specific Date, Not a Promise
KBR announced the MTS spinoff in September 2025. The effective date is January 4, 2027, chosen to align with the fiscal year and allow time for complex IT system separations.
A spinoff with a specific date and a reason for it is further along than one with vague mid-year language.
The spinoff just got more concrete. In late June 2026, KBR named Michael LaRouche as President and CEO designate of the future MTS company and Nicholas Veasey as Executive Vice President and CFO designate.
You do not appoint a dedicated CEO and CFO to a spinoff that is at risk of not happening. Those appointments are the clearest signal yet that January 4, 2027, is real.
Spinoff effective date: January 4, 2027: A specific date, not a range.
Michael LaRouche named President and CEO designate of MTS: Leadership team in place months before separation.
Nicholas Veasey named EVP and CFO designate of MTS: Financial leadership confirmed for the standalone entity.
Once MTS trades independently, investors holding KBR today own shares in both companies. MTS is finally valued against defense-tech peers rather than averaged with the broader engineering business.
Action: On each call before January 2027, listen for MTS separation language. January 4 is confirmed as the signal to hold.
Any pushed timeline means reducing before the catalyst disappears.
New energy (Sponsored)
Decades ago, major oil companies explored an energy source they ultimately left behind.
Today, advances in technology have renewed interest in that same resource, and one analyst believes a single company may be uniquely positioned to benefit.
His free briefing explains why investors are paying attention.
Watch the Free Briefing
Two Businesses Are Stuck Sharing One Multiple, and That Is the Entire Valuation Problem
The engineering and government services business is the textbook conglomerate discount story. KBR houses two fundamentally different businesses.
The Mission Technology Solutions segment does classified defense work, hypersonics research, space systems, and specialized cyber capabilities for US defense and intelligence agencies.
The Sustainable Technology Solutions segment is energy and industrial engineering, with longer-cycle project work.
Pure-play defense-tech companies focused on the work MTS does trade at meaningfully higher multiples than engineering contractors.
Leidos and Booz Allen Hamilton have carried mid-teens forward multiples for years because the market gives full credit to their government technology positioning.
KBR’s entire company sits at roughly 8x forward earnings because the market averages both businesses together and applies the lower engineering multiple across the whole thing.
That is the discount. It is mechanical, and it resolves the moment MTS trades separately.
Forward P/E roughly 8x on $4.05 full-year EPS guidance midpoint: Among the cheapest in the defense services group.
Defense-tech peers like Leidos and Booz Allen carry mid-teens multiples: MTS should command a similar re-rating once independent.
Average analyst target approximately $46-$47: The stock at $33 is roughly 25% below where analysts think it belongs.
The math does not require heroic assumptions. You need MTS to trade closer to defense-tech peers and the remaining KBR to trade as a focused industrial technology company. Neither piece would carry the discount the combined entity carries today.
Action: Compare KBR’s forward multiple against Leidos and Booz Allen each quarter. A widening gap before the spinoff means the opportunity is growing.
A narrowing gap means the market is already pricing it in.
Q1 2026 Beat Estimates and Management Reaffirmed the Full Year Despite Headwinds
KBR reported Q1 2026 on May 7. Revenue came in at approximately $1.9 billion, down 5% year over year due to the planned EUCOM drawdown. EPS of $0.96 beat the $0.94 estimate.
Adjusted EBITDA margins expanded from 12.3% to 13.1% year over year. Adjusted operating cash flow rose to $119 million, up $28 million year over year.
Management reaffirmed full-year 2026 guidance of $3.87 to $4.22 adjusted EPS and $7.90 to $8.36 billion in revenue, acknowledging EUCOM headwinds and spinoff preparation costs.
The margin expansion in Q1 happened while managing the complexity of a corporate separation. Getting margins higher while running a spinoff tells you the underlying business is in good shape.
Q1 EPS $0.96 beat estimates; revenue fell 5% on EUCOM drawdown: A mixed quarter where profitability held up.
Adjusted operating cash flow $119M, up $28M year over year: Cash generation accelerating while managing the spinoff.
Full-year adjusted EPS guidance of $3.87 to $4.22 reaffirmed: Management held every guidance line.
STS showed momentum too. Underlying margins at 16.1% excluding a large LNG project, with management targeting above 20% as technology licensing replaces LNG work. A deliberate roadmap.
Action: On the Q2 call, if operating cash flow stays above $100M and full-year guidance holds, two consecutive confirmed quarters alongside the spinoff are the signal to add.
How KBR Stacks Up Against the Peer Group at Current Prices
KBR sits in two different worlds and gets valued at the lower end of both. Defense-tech names like Leidos and Booz Allen carry richer multiples.
Industrial engineering names focused on energy and process technology do not. KBR has both, and the market splits the difference unfavorably.
Analyst consensus sits around $46-$47. Citi trimmed to $50 from $53 but kept a Buy. At $33, you are buying 25% below consensus. That does not mean the analysts are right.
It means the current price is not what most people who study the company closely think it is worth.
25% below average analyst target: That gap has widened as the stock fell.
Citi Buy-rated at $50 target post-trim: The most recent target reduction still implies over 50% upside.
Insider buying at current prices: Both the CFO and a director think $33 is a deal.
The stock has been punished partly by the EUCOM headwind, partly by investors who are impatient with the spinoff timeline, and partly by the sector-wide pressure on government services names. None of those are permanent.
The contracts keep coming, the margins are expanding, and the spinoff is gaining concrete detail with each passing month.
Action: Any pullback toward $30 before the spinoff closes is a better entry. The closer January 2027 gets, the more the discount should compress.
Poll: What's your process for sizing a position when you're early in building conviction?
The Risks Are Specific, and the Biggest One Is Within Management’s Control
The spinoff getting delayed is the primary risk. January 4, 2027, is a specific date, but corporate separations are complex.
If the IT system separation takes longer than expected, if regulatory filings hit unexpected friction, or if management decides to restructure the terms, the catalyst timeline stretches.
The appointment of dedicated leadership for MTS reduces this risk materially, but it does not eliminate it.
The second risk is government contract exposure. A meaningful shift in defense budget priorities, a continuing-resolution environment that freezes new contract awards, or a loss on a major renewal hits backlog and forward revenue visibility.
The EUCOM work that declined in Q1 is a real example: one segment of government work shifted, and it hit top-line revenue that quarter. Backlog is the number to watch every quarter.
Spinoff delay risk: IT system separations take longer than planned more often than not.
Government contract concentration: EUCOM headwind in Q1 showed how a single program shift moves the needle.
Neither is existential at 8x forward earnings with named spinoff leadership, insider buying, and two June contract wins. But spinoff timelines slip, and government budgets are not predictable.
Action: Hard stop at $28. EPS below $0.90 plus a pushed spinoff timeline in the same quarter means both theses broke. Exit at $28.
Final Word: A Spinoff Getting More Concrete Every Week With Insiders Already Positioned
37% off its high. CFO bought stock. Two defense contracts in June. Named spinoff leadership. Margins are expanding while managing the separation. The conglomerate discount is mechanical, and it resolves in January 2027.
Buy KBR at $32-$34. Hard stop $28. Target $46-$50.
Setup Scorecard
Entry Window: $32-$34. The stock is 37% below its 52-week high and 25% below the analyst consensus. Insider buying happened at these levels.
Catalyst Watch: January 4, 2027, spinoff effective date, Q2 2026 earnings for margin and cash flow trajectory, any MTS separation milestones, additional insider Form 4 filings.
Upside Setup: MTS separates on schedule, trades at defense-tech peer multiples, and the remaining KBR re-rates as a focused industrial technology company. Target $46-$50 over 12-18 months.
Downside Cushion: 8x forward earnings at current prices, $119M quarterly operating cash flow, $4.7B STS backlog growing at 9%, $95M and $8B contracts won in June 2026, CFO and director buying personally.
What Moves It Next: Q2 earnings, operating cash flow and EPS versus the $3.87 to $4.22 full-year guide, any MTS separation update, additional defense contract announcements from the MTS pipeline, and the Form 4 filing trend from insiders.
That's our coverage for today; thanks for reading! Reply to this email with feedback or any value names you want me to check out.
Best Regards,
—Noah Zelvis
Undervalued Edge
